105 related articles for article (PubMed ID: 23792609)
21. Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data.
Reddy BP; Adams R; Walsh C; Barry M; Kind P
Value Health; 2015 Sep; 18(6):841-5. PubMed ID: 26409612
[TBL] [Abstract][Full Text] [Related]
22. Patient preferences for side effects associated with cervical cancer treatment.
Sun C; Brown AJ; Jhingran A; Frumovitz M; Ramondetta L; Bodurka DC
Int J Gynecol Cancer; 2014 Jul; 24(6):1077-84. PubMed ID: 24905618
[TBL] [Abstract][Full Text] [Related]
23. Elicitation of utility scores in Canada for immune thrombocytopenia treated with romiplostim or watch and rescue.
Iskedjian M; Tinmouth AT; Arnold DM; Deuson R; Isitt JJ; Mikhael J
J Med Econ; 2012; 15(2):313-31. PubMed ID: 22136485
[TBL] [Abstract][Full Text] [Related]
24. [Empirical research of measuring elderly health utility in the outskirts of Beijing by using European quality of life 5-dimensions].
Wu YQ; Liu K; Tang X; Cao Y; Wang JW; Li N; Liu JJ; Yu LP; Xu HT; Liu WJ; Wen SS; Hu YH; Li K
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):397-402. PubMed ID: 22692310
[TBL] [Abstract][Full Text] [Related]
25. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
[TBL] [Abstract][Full Text] [Related]
26. Health state utility scores for cancer-related anemia through societal and patient valuations.
Lloyd A; van Hanswijck de Jonge P; Doyle S; Cornes P
Value Health; 2008 Dec; 11(7):1178-85. PubMed ID: 19602216
[TBL] [Abstract][Full Text] [Related]
27. Patient Preferences for Minimally Invasive and Open Locoregional Treatment for Early-Stage Breast Cancer.
Knuttel FM; van den Bosch MA; Young-Afat DA; Emaus MJ; van den Bongard DH; Witkamp AJ; Verkooijen HM
Value Health; 2017 Mar; 20(3):474-480. PubMed ID: 28292493
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.
Lee YC; Wang L; Kohn EC; Rubinstein L; Ivy SP; Harris PJ; Lheureux S
Cancer; 2020 May; 126(10):2139-2145. PubMed ID: 32097505
[TBL] [Abstract][Full Text] [Related]
29. Do the 15D scores and time trade-off (TTO) values of hospital patients' own health agree?
Honkalampi T; Sintonen H
Int J Technol Assess Health Care; 2010 Jan; 26(1):117-23. PubMed ID: 20059789
[TBL] [Abstract][Full Text] [Related]
30. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
[TBL] [Abstract][Full Text] [Related]
31. Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe.
Golicki D; Jakubczyk M; Niewada M; Wrona W; Busschbach JJ
Value Health; 2010; 13(2):289-97. PubMed ID: 19744296
[TBL] [Abstract][Full Text] [Related]
32. Examination of assumptions in using time tradeoff and standard gamble utilities in individuals with spinal cord injury.
Lin MR; Yu WY; Wang SC
Arch Phys Med Rehabil; 2012 Feb; 93(2):245-52. PubMed ID: 22289233
[TBL] [Abstract][Full Text] [Related]
33. Validity of utility measures for women with pelvic organ prolapse.
Harvie HS; Lee DD; Andy UU; Shea JA; Arya LA
Am J Obstet Gynecol; 2018 Jan; 218(1):119.e1-119.e8. PubMed ID: 28988907
[TBL] [Abstract][Full Text] [Related]
34. Health state utilities associated with attributes of treatments for hepatitis C.
Matza LS; Sapra SJ; Dillon JF; Kalsekar A; Davies EW; Devine MK; Jordan JB; Landrian AS; Feeny DH
Eur J Health Econ; 2015 Dec; 16(9):1005-18. PubMed ID: 25481796
[TBL] [Abstract][Full Text] [Related]
35. Deriving a patient-based utility index from a cancer-specific quality of life questionnaire.
Grimison PS; Simes RJ; Hudson HM; Stockler MR
Value Health; 2009; 12(5):800-7. PubMed ID: 19508665
[TBL] [Abstract][Full Text] [Related]
36. Exploring Differences between TTO and DCE in the Valuation of Health States.
Robinson A; Spencer AE; Pinto-Prades JL; Covey JA
Med Decis Making; 2017 Apr; 37(3):273-284. PubMed ID: 27646566
[TBL] [Abstract][Full Text] [Related]
37. Performance status and symptom scores of women with gynecologic cancer at the end of life.
Spoozak L; Seow H; Liu Y; Wright J; Barbera L
Int J Gynecol Cancer; 2013 Jun; 23(5):971-8. PubMed ID: 23666015
[TBL] [Abstract][Full Text] [Related]
38. Elicitation of health state utilities associated with differing durations of morning stiffness in rheumatoid arthritis.
Iqbal I; Dasgupta B; Taylor P; Heron L; Pilling C
J Med Econ; 2012; 15(6):1192-200. PubMed ID: 22804691
[TBL] [Abstract][Full Text] [Related]
39. Utilities for treatment-related adverse events in type 2 diabetes.
Shingler S; Fordham B; Evans M; Schroeder M; Thompson G; Dewilde S; Lloyd AJ
J Med Econ; 2015 Jan; 18(1):45-55. PubMed ID: 25266815
[TBL] [Abstract][Full Text] [Related]
40. The impact of living with a functional and aesthetic nasal deformity after primary rhinoplasty: a utility outcomes score assessment.
Sinno H; Izadpanah A; Thibaudeau S; Christodoulou G; Tahiri Y; Slavin SA; Lin SJ
Ann Plast Surg; 2012 Oct; 69(4):431-4. PubMed ID: 22964667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
